These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1687943

  • 1. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
    Musto P, Lombardi G, Matera R, Carotenuto M.
    Haematologica; 1991; 76(6):513-6. PubMed ID: 1687943
    [Abstract] [Full Text] [Related]

  • 2. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L, Jarque I, Martín G, Sempere A, González-García Y, Gomis F, Pérez-Sirvent M, De La Rubia J, Sanz MA.
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [Abstract] [Full Text] [Related]

  • 3. [p170 in multiple myeloma and acute leukemia].
    Riccardi A, Invernizzi R, Ucci G, Luoni R, Danova M, Giordano M, Zambelli ML, Rastaldi MP, Ascari E.
    Haematologica; 1991 Jun; 76 Suppl 3():177-80. PubMed ID: 1684345
    [No Abstract] [Full Text] [Related]

  • 4. [Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].
    Musto P, Carotenuto M.
    Haematologica; 1991 Jun; 76 Suppl 3():169-72. PubMed ID: 1684343
    [No Abstract] [Full Text] [Related]

  • 5. P-glycoprotein expression in multiple myeloma.
    Carulli G, Petrini M, Marini A, Ambrogi F, Ucci G, Riccardi A, Luoni R, Grassi B.
    Haematologica; 1990 Jun; 75(3):288-90. PubMed ID: 1977668
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P, Hegewisch-Becker S, Godfrey L, Andreeff M.
    Cytometry; 1994 Sep 01; 17(1):84-93. PubMed ID: 8001461
    [Abstract] [Full Text] [Related]

  • 7. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW, Lee J, Wang RM, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Cancer Res; 1989 Sep 01; 49(17):4829-34. PubMed ID: 2569359
    [Abstract] [Full Text] [Related]

  • 8. [Multidrug resistance in acute nonlymphoid leukemia].
    Michieli M, Geromin A, Damiani D, Michelutti A, Raspadori D, Masotti A, Russo D, Fanin R, Fasola G, Mallardi F.
    Haematologica; 1991 Jun 01; 76 Suppl 3():165-8. PubMed ID: 1684342
    [No Abstract] [Full Text] [Related]

  • 9. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.
    Grogan T, Dalton W, Rybski J, Spier C, Meltzer P, Richter L, Gleason M, Pindur J, Cline A, Scheper R.
    Lab Invest; 1990 Dec 01; 63(6):815-24. PubMed ID: 1979362
    [Abstract] [Full Text] [Related]

  • 10. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission.
    Musto P, Melillo L, Lombardi G, Matera R, di Giorgio G, Carotenuto M.
    Br J Haematol; 1991 Jan 01; 77(1):50-3. PubMed ID: 1671821
    [Abstract] [Full Text] [Related]

  • 11. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
    Müller MR, Lennartz K, Nowrousian MR, Dux R, Tsuruo T, Rajewsky MF, Seeber S.
    Cytometry; 1994 Jan 01; 15(1):64-72. PubMed ID: 7512893
    [Abstract] [Full Text] [Related]

  • 12. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A.
    Cancer Res; 1998 Jan 15; 58(2):256-62. PubMed ID: 9443402
    [Abstract] [Full Text] [Related]

  • 13. MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.
    Cornelissen JJ, Sonneveld P, Schoester M, Raaijmakers HG, Nieuwenhuis HK, Dekker AW, Lokhorst HM.
    J Clin Oncol; 1994 Jan 15; 12(1):115-9. PubMed ID: 7903690
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL.
    Semin Hematol; 1997 Oct 15; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma.
    Rutledge ML, Robey-Cafferty SS, Silva EG, Bruner JM.
    Mod Pathol; 1990 May 15; 3(3):298-301. PubMed ID: 1972985
    [Abstract] [Full Text] [Related]

  • 16. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P.
    Srp Arh Celok Lek; 1996 May 15; 124(11-12):292-6. PubMed ID: 9132962
    [Abstract] [Full Text] [Related]

  • 17. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
    Filipits M, Drach J, Pohl G, Schuster J, Stranzl T, Ackermann J, Königsberg R, Kaufmann H, Gisslinger H, Huber H, Ludwig H, Pirker R.
    Clin Cancer Res; 1999 Sep 15; 5(9):2426-30. PubMed ID: 10499614
    [Abstract] [Full Text] [Related]

  • 18. The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia.
    Savignano C, Geromin A, Michieli M, Damiani D, Michelutti A, Melli C, Fanin R, Baccarani M.
    Haematologica; 1993 Sep 15; 78(5):261-3. PubMed ID: 7906239
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
    Luo SK, Li J, Hong WD, Zhao Y, Tong XZ.
    Ai Zheng; 2005 Dec 15; 24(12):1518-21. PubMed ID: 16351805
    [Abstract] [Full Text] [Related]

  • 20. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R.
    Clin Cancer Res; 1997 Aug 15; 3(8):1419-25. PubMed ID: 9815827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.